Match Document Document Title
6761900 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same  
Topical patch preparations that contain a delayed-type hypersensitivity inducer, e.g., 1-dichloro-2,4-dinitrobenzene (DNCB), and methods for using the same are provided. The subject topical patch...
6759053 S(&plus ) Desmethylselegiline and its use to treat ADHD  
The present invention provides novel compositions and methods for using the S(+) enantiomer of desmethylselegiline (N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane), for the treatment of...
6756053 Controlled heat induced rapid delivery of pharmaceuticals from skin depot  
The present invention is directed to a method and system for delivering a drug into the systemic circulation. The method comprises establishing a drug depot in a patient's skin and/or sub-skin...
6756051 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same  
Bioadhesive, closed-cell foam film, sustained release, delivery devices for administering an active agent or combination of active agents to a subject are provided. Methods for making such delivery...
6756052 Device and method for increasing the transdermal permeation of medicaments  
The invention relates to a device and a method for increasing the transdermal permeation of medications. The invention is characterized in that a constituent which effects a local increase in...
6750291 Film-forming agent for drug delivery and preparation for percutaneous administration containing the same  
The present invention relates to a film-forming agent which forms a film on the skin, and also to a preparation for percutaneous administration containing the film-forming agent and active...
6746689 Intradermal-penetration agents for topical local anesthetic administration  
A non-invasive and non-systemic method for administering a local anesthetic. The method comprises topical application of a local anesthetic in combination with an intradermal-penetration agent...
6746688 Apparatus for the transdermal treatment of Parkinson's disease  
A pharmaceutical composition for treatment of Parkinson's disease comprising a compound of levodopa dissolved in a non-degradative solvent which allows transdermal administrtion of levodopa. The...
6743432 Interface for iontophoresis  
A hydrophilic membrane having a low adsorptivity for a protein is disposed, as an interface, on a side to be contacted with a skin, and a drug such as a physiologically active peptide is...
6743211 Devices and methods for enhanced microneedle penetration of biological barriers  
Microneedle devices and methods of use thereof are provided for the enhanced transport of molecules, including drugs and biological molecules, across tissue by improving the interaction of...
6737080 Composite laminate and method for its production  
The invention relates to a composite laminate, especially a transdermal therapeutic system (TTS) that contains in at least one layer a component that is sensitive to moisture. Said system further...
6733773 Paper products treated with oil-in-water emulsions  
A paper product that is applied with a lotion composition is provided. In one embodiment of the present invention, the lotion composition includes water in an amount up to about 90% by weight of...
6733775 Plastic films, especially for use in a dermal or transdermal therapeutic system  
A dermal or transdermal therapeutic system comprising a sheet-like substrate or reservoir containing readily volatile auxiliary agents or active agents, which substrate or reservoir is covered on...
6730318 Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties  
The adhesive capability of matrix-type transdermal devices for the delivery of drugs, cosmetics, emollients and the like is altered by incorporating into the pressure-sensitive adhesive an...
6730317 Patch, a kit constituted by a patch and a receptacle and a method  
A patch comprising a matrix having adhesive properties in the dry state and containing at least one active substance, said matrix being attached via one face to a backing and being for application...
6727401 Pressure sensitive adhesive matrix patch for the treatment of onychomycosis  
A device for treating antifungal infections of toenails and fingernails is made up of an occlusive backing layer and a pressure sensitive adhesive matrix layer in which is uniformly dispersed an...
6726920 Implantable drug delivery patch  
The present invention features devices and methods for delivery of drug to an internal organ surface by delivery of drug directly to the surface of the organ such that the drug traverses the organ...
6726673 Methods and apparatus for improved administration of testosterone pharmaceuticals  
The present invention relates to a method and apparatus for increasing the delivery rate of an androgen transdermal therapeutic system through the skin. An androgen transdermal therapeutic system...
6723337 Transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof  
The invention herein relates to a transdermal drug delivery systern for anti-Inflammatory analgesic. agent comprising diclofenac diethylammonium salt, wherein a backing film ( 1 ), a matrix layer (...
6723306 Article for applying artificial tanning agent and method of making  
An article for applying a skin care product, particularly an artificial tanning agent to the skin. The article includes an adhesive matrix disposed between at least two layers that are permanently...
6720356 Magnesium di-potassium EDTA complex and method of administration  
A composition containing an EDTA complex in the form of a suppository is provided. More specifically, the EDTA complex is a magnesium di-potassium EDTA complex. The suppository may contain a...
6721595 Percutaneous absorption promoters for electroporation  
The present invention relates to percutaneous sorbefacients for electroporation consisting of monoterpene and being useful in elevating percutaneous absorbability of drugs, etc. By adding these...
6719997 Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers  
Methods, compositions and drug delivery systems are provided for the transdermal administration of a pharmacologically active amine. The active agent is administered with a hydroxide-releasing...
6716449 Controlled-release compositions containing opioid agonist and antagonist  
Controlled-release dosage forms containing an opioid agonist; an opioid antagonist; and a controlled release material release during a dosing interval an analgesic or sub-analgesic amount of the...
6716441 Compositions for efficient release of active ingredients  
The present invention relates to a novel composition for efficiently releasing hydrophilic or water-soluble skin care actives from an oleaginous composition. The substantially oleaginous...
6713084 Methods for promoting healing of skin resurfacing wounds  
The present invention provides methods for promoting healing of wounds which result from skin resurfacing procedures, e.g., from laser surgery to remove or alter superficial features of the skin....
6709664 Methods for treating photodamaged skin by administering selegiline or desmethylselegiline  
The present invention is directed to methods that can be used in the treatment of wounds, burns, and photodamaged skin. Methods can be used for both humans and animals and involve the...
6706279 Wound dressing  
Provided herein is a disinfectant wound dressing for treating tissue wounds, said dressing comprising a hydrogel matrix including an absorbent fibrous material comprising alginate salt, said...
6706274 Differential delivery of nitric oxide  
This invention relates to devices and methods for the local, differential delivery of nitric oxide within the body. The devices include devices having at least two differing nitric oxide donor...
6703444 Process for cross-linking hyaluronic acid to polymers  
The present invention relates to a process for the production of hyaluronic acid (HA) derivatives. In particular, the process relates to multiple cross-linked hyaluronic acid derivatives, to navel...
6703043 Substance release device  
The invention relates to a device for releasing active agents, characterized in that at a frequency of 0.1 rad/s, it has a glass transition temperature of less than 15° C., contains at least 3% by...
6699498 Transdermal therapeutic systems having improved stability and their production  
This invention provides for, inter alia, a transdermal therapeutic system comprising at least one therapeutically active substance, which is oxidizable by hydroperoxides, wherein the amount of...
6696078 System and methods for local intradermal treatment  
A system and methods for local intradermal treatment of a dermal injury carrying the risk of innoculation with an identified pathogen or pathogens carried by an identified vector is described. In...
6692763 Methods for treating postmenopausal women using ultra-low doses of estrogen  
The present invention provides methods for treating physical conditions resulting from postmenopausel estrogen decline in a postmenopausel subject, and in particular methods for reducing the risk...
6689379 Transdermal therapeutic system with neutralized acrylic adhesive patch  
A transdermal therapeutic system embodied as a matrix or reservoir system is characterized by a content of at least one basic- or neutral-reacting pharmaceutical active agent a content of a...
6689380 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy  
The present invention provides a method/system for remote and local controlled delivery of pharmaceutical compounds or biomolecule collection using electromagnetic energy. Controlled...
6689373 Devices and methods for pain management  
The invention features devices and methods for the systemic delivery of fentanyl or a fentanyl congener (e.g., sufentanil) to treat pain. In the present invention, a drug formulation comprising...
6685959 Pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives  
The invention relates to novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives. The invention more specifically relates to compositions in the form of a patch...
6682757 Titratable dosage transdermal delivery system  
The present invention relates to a titratable dosage transdermal delivery system for systemic delivery of a therapeutic agent or drug. The system comprises a plurality of patch units that are...
6680067 Controlled-release pharmaceutical preparation containing nalbuphine and a process for preparing the same  
A controlled-release pharmaceutical preparation containing an oil suspension which comprises an analgesic and an injectable oil. The analgesic is either a nalbuphine free base or a pharmaceutical...
6676959 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption  
Formulations of nicotine for use in nicotine replacement therapy. The formulations are intended for application in the oral cavity where upon the uptake of nicotine mainly takes place through the...
6676961 Transdermal patch assembly  
A transdermal patch assembly includes a pressure sensitive carrier having a central opening, one side being provided with a clear liner thereon extending across the central opening, and an opposite...
6676962 Topical plaster with non-steroidal antirheumatic agents with an acid group  
A topical patch having non-steroid antirheumatic agent as active substance, consisting of a backing layer inert to the active substance, a self-adhesive, active substance-containing matrix layer...
6676960 Intraoral adhesive preparation  
An intraoral adhesive preparation is provided, which contains a support made of a nonwoven fabric mainly made of split type conjugated fibers, and an adhesive plaster layer containing a drug, which...
6673363 Transdermal and topical administration of local anesthetic agents using basic enhancers  
Methods are provided for enhancing the permeability of skin or mucosal tissue to topical or transdermal application of local anesthetic agents. The methods entail the use of a base in order to...
6669953 Block copolymer  
Cross-linked block copolymers are disclosed which have drug retention properties, comprising hard and soft segments, with cross-linking between the soft segments. The block copolymers can be based...
6667052 Transdermal delivery system  
The invention provides a transdermal delivery system for treating diabetes and other pathologic systemic conditions, comprising an active ingredient selected from the group consisting of peptides...
6666747 Method for embellishing the shape of a human body by means of a cosmetic plaster  
A method for embellishing the shape of a human body utilizes a cosmetic plaster and suitable embodiments of cosmetic plasters. The cosmetic plaster is attached on the one hand, to skin over loose...
6660295 Transdermal drug delivery device package with improved drug stability  
This invention relates to the field of transdermal drug delivery devices and more particularly to improved storage stability thereof. The invention comprises providing a transdermal drug delivery...
6656491 Active substance plasters  
Active substance plasters consisting of a backing material and an at least partially applied adhesive composition, characterized in that a component comprising one or more active substances is...